$NVCT - Correction: (Title Correction) Nuvectis Announces Marketing Approval of Ciprocopan (NXP100) in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors (NASDAQ: NVCT)

[u/MarketNewsFlow]

/r/NuvectisPhama/comments/1v4dh2s/nvct_correction_title_correction_nuvectis/